GraftCath (Coon Rapids, MN) a commercialization stage medical device company focused on reducing infections for dialysis patients closed a $11.8M Series D financing. Participants include Affinity Capital Management, Ascension Health Ventures, Cutlass Capital, Sapient Capital and Three Arch Partners.